These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8090451)

  • 1. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.
    Glacet-Bernard A; Chabanel A; Lelong F; Samama MM; Coscas G
    Ophthalmology; 1994 Sep; 101(9):1483-7. PubMed ID: 8090451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of rheologic factors in patients with acute central retinal vein occlusion.
    Arend O; Remky A; Jung F; Kiesewetter H; Reim M; Wolf S
    Ophthalmology; 1996 Jan; 103(1):80-6. PubMed ID: 8628564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
    Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
    Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for retinal vein occlusion: prospective study of 175 cases.
    Glacet-Bernard A; Coscas G; Chabanel A; Zourdani A; Lelong F; Samama MM
    Ophthalmology; 1996 Apr; 103(4):551-60. PubMed ID: 8618752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased red blood cell aggregation in retinal vein occlusion.
    Chabanel A; Glacet-Bernard A; Lelong F; Taccoen A; Coscas G; Samama MM
    Br J Haematol; 1990 May; 75(1):127-31. PubMed ID: 2375911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of plasmapheresis on the rheological properties of the blood in patients with thrombosis of the central retinal vein].
    Komashchuk AS; Zhaboedov GD; Karpovich LG
    Lik Sprava; 1999 Mar; (2):45-7. PubMed ID: 10424039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion.
    Wautier MP; Héron E; Picot J; Colin Y; Hermine O; Wautier JL
    J Thromb Haemost; 2011 May; 9(5):1049-55. PubMed ID: 21362128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
    Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
    Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheologic findings in patients with acute central retinal artery occlusion.
    Kieswetter H; Körber N; Jung F; Reim M
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(2):92-5. PubMed ID: 6862190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
    Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
    Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isovolemic hemodilution in central retinal vein occlusion.
    Glacet-Bernard A; Zourdani A; Milhoub M; Maraqua N; Coscas G; Soubrane G
    Graefes Arch Clin Exp Ophthalmol; 2001 Dec; 239(12):909-14. PubMed ID: 11820695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.
    Arch Ophthalmol; 1996 May; 114(5):545-54. PubMed ID: 8619763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemorheology in patients with branch retinal vein occlusion with and without risk factors.
    Remky A; Arend O; Jung F; Kiesewetter H; Reim M; Wolf S
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S8-12. PubMed ID: 8871143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheologic variables in critical limb ischemia before and after infrainguinal reconstruction.
    Holmberg A; Sandhagen B; Bergqvist D
    J Vasc Surg; 2000 Apr; 31(4):691-5. PubMed ID: 10753276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
    Cortinovis A; Crippa A; Crippa M
    Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.
    Williamson TH; Rumley A; Lowe GD
    Br J Ophthalmol; 1996 Mar; 80(3):203-8. PubMed ID: 8703856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.
    Lahiri KD; Mukherjee S; Ghosh S; Mukherjee S; Dutta J; Datta H; Das HN
    Korean J Ophthalmol; 2015 Apr; 29(2):86-91. PubMed ID: 25829824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
    Dong N; Xu B; Tang X
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.